cbdMD, Inc.
YCBD
$0.49
-$0.01-1.56%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 20.55% | 18.75% | -1.89% | 3.61% | -10.96% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 20.55% | 18.75% | -1.89% | 3.61% | -10.96% |
| Cost of Revenue | 41.70% | 33.13% | 17.67% | -7.56% | 0.30% |
| Gross Profit | 7.29% | 10.05% | -11.74% | 13.18% | -16.82% |
| SG&A Expenses | 22.77% | 24.26% | 3.09% | 2.74% | -2.31% |
| Depreciation & Amortization | -7.57% | -12.00% | -17.65% | -8.93% | -2.64% |
| Other Operating Expenses | -78.00% | -62.14% | -76.24% | 150.55% | 11.08% |
| Total Operating Expenses | 21.28% | 23.03% | 1.99% | 10.95% | -0.80% |
| Operating Income | -24.96% | -64.84% | -231.75% | -116.61% | -136.83% |
| Income Before Tax | -25.90% | -65.97% | -1,974.83% | -345.03% | -294.76% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -25.90% | -65.97% | -1,974.83% | -345.03% | -294.76% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -25.90% | -65.97% | -1,974.83% | -345.03% | -294.76% |
| EBIT | -24.96% | -64.84% | -231.75% | -116.61% | -136.83% |
| EBITDA | -39.55% | -174.74% | -119.27% | -1,371.53% | -562.25% |
| EPS Basic | 46.87% | 95.59% | 97.92% | 93.71% | 82.35% |
| Normalized Basic EPS | 31.40% | 87.55% | 76.03% | 76.90% | 82.38% |
| EPS Diluted | 46.87% | 95.59% | 97.92% | 93.71% | 82.35% |
| Normalized Diluted EPS | 31.40% | 87.55% | 76.03% | 76.90% | 82.38% |
| Average Basic Shares Outstanding | 83.57% | 1,241.68% | 1,482.43% | 835.69% | 1,187.78% |
| Average Diluted Shares Outstanding | 83.57% | 1,241.68% | 1,482.43% | 835.69% | 1,187.78% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |